ABT vs BAX
Abbott Laboratories (ABT) and Baxter International (BAX) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $13.1B for Baxter International, about 13.7 times the size. BAX returned +10.3% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026..
Head to head
| Metric | ABT | BAX |
|---|---|---|
| Market cap | $179.4B | $13.1B |
| P/E (TTM) | 38.6x | — |
| Forward P/E | 17.4x | 12.4x |
| Revenue (TTM) | $48.2B | $11.5B |
| Revenue growth | 14.5% | 5.3% |
| Gross margin | 57.1% | 34.1% |
| Operating margin | 11.3% | 14.4% |
| Free cash flow | $7.4B | $812.0M |
| Dividend yield | 2.43% | 0.16% |
| 1-year return | -15.9% | +10.3% |
| 5-year return (annual) | -2.0% | -19.4% |
| Max drawdown | -46% | -81% |
| FI Handbook grade | C+ | D+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$5.0K
$10.0K
20222023202420252026
ABT vs BAX FAQ
Which is bigger, ABT or BAX?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $13.1B for Baxter International, about 13.7 times the size.
Which stock performed better over the past year, ABT or BAX?
BAX returned +10.3% over the past year including dividends, versus -15.9% for ABT, through October 23, 2026.
Which pays a higher dividend, ABT or BAX?
ABT yields 2.43% versus 0.16% for BAX.
Full pages: Abbott Laboratories · Baxter International